Dearth of glutamate transporters contributes to striatal excitotoxicity

Tatiana Brustovetsky, Kevin Purl, Anisa Young, Kazuyuki Shimizu, Janet M. Dubinsky

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Since excitotoxicity is hypothesized to contribute to cell death in Huntington's disease (HD), we examined the susceptibility of striatal and hippocampal neurons to glutamate-induced cell death. Striatal cultures were more susceptible to glutamate-triggered toxicity than sister hippocampal cultures. Dose-response curves were equivalent when secondary toxicity was blocked with application of the NMDA receptor antagonist, MK801, or enhanced with the pan-specific glutamate transport blocker, TBOA, following excitotoxin removal. TBOA failed to alter the dose-response characteristics of striatal excitotoxicity, ruling out reverse operation of glutamate transporters. Striatal cultures expressed less EAAC1and less membrane-associated EAAC1, GLT1, and GLAST than hippocampal cultures. Antisense down-regulation of EAAC1 increased the sensitivity of hippocampal cultures to glutamate, indicating that this transporter can act as an important neuroprotectant. Thus, the relative expression levels of glutamate transporters, even in parts of the brain where they are considered adequately expressed, appear to influence the sensitivities of different neuronal populations to excitotoxicity.

Original languageEnglish (US)
Pages (from-to)222-230
Number of pages9
JournalExperimental Neurology
Volume189
Issue number2
DOIs
StatePublished - Oct 1 2004

Keywords

  • Anionic liposomes
  • EAAC1
  • GLAST
  • GLT1
  • Glutamate transporters
  • Huntington's disease
  • Neurodegeneration
  • Selective vulnerability

Fingerprint Dive into the research topics of 'Dearth of glutamate transporters contributes to striatal excitotoxicity'. Together they form a unique fingerprint.

Cite this